STOCK TITAN

UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference in Toronto, hosting one-on-one meetings with investors and a presentation on April 16. The event will be webcasted on the company's website.
Positive
  • None.
Negative
  • None.

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- NOTE: The new presentation time for Aurinia’s presentation at the 2024 Bloom Burton & Co. Healthcare Investor Conferences is 4:00 to 4:30 PM Eastern Time. This event is presentation only. Webcast Details remain the same.

The updated release reads:

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention Centre in Toronto from April 16-17, 2024.

Aurinia management will host one-on-one meetings with investors and will host a presentation on Tuesday, April 16, from 4:00 to 4:30 PM Eastern Time. A live webcast of the session will be available on the investor section of Aurinia’s website, which can be found here.

About Aurinia

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy dedicated to the treatment of adult patients with active lupus nephritis. The Company’s head office is in Edmonton, Alberta, its U.S. commercial office is in Rockville, Maryland. The Company focuses its development efforts globally.

Media and Investor Inquiries:

Andrea Christopher

Corporate Communications and Investor Relations, Aurinia

achristopher@auriniapharma.com

ir@auriniapharma.com

Source: Aurinia Pharmaceuticals Inc.

Aurinia's presentation is scheduled for Tuesday, April 16, from 4:00 to 4:30 PM Eastern Time.

The conference will be held at the Metro Toronto Convention Centre in Toronto.

Yes, Aurinia management will host one-on-one meetings with investors during the event.

Yes, a live webcast of the presentation will be accessible on Aurinia's website.
Aurinia Pharmaceuticals Inc

NASDAQ:AUPH

AUPH Rankings

AUPH Latest News

AUPH Stock Data

724.53M
131.74M
7.45%
38.61%
8.47%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
EDMONTON

About AUPH

aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada.